应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01530 三生制药
未开盘 01-14 16:08:06
27.320
-1.000
-3.53%
最高
28.800
最低
26.620
成交量
3,677万
今开
28.580
昨收
28.320
日振幅
7.70%
总市值
693.38亿
流通市值
693.38亿
总股本
25.38亿
成交额
10.07亿
换手率
1.45%
流通股本
25.38亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股创新药概念股盘初普涨!乐普生物-B涨超8%,药明康德涨超7%
老虎资讯综合 · 01-13 09:45
港股创新药概念股盘初普涨!乐普生物-B涨超8%,药明康德涨超7%
蔓迪国际的两重隐忧:脱发产品或被集采,减肥药又难破“双寡头”格局
新财观 · 01-12 17:15
蔓迪国际的两重隐忧:脱发产品或被集采,减肥药又难破“双寡头”格局
JPM 2026前瞻 | 中国创新药站上全球舞台中央
Ofweek光电信息网 · 01-12 16:58
JPM 2026前瞻 | 中国创新药站上全球舞台中央
中国力量在JPM大会的闪耀时刻:24家国产企业双线发力
药渡 · 01-12 16:36
中国力量在JPM大会的闪耀时刻:24家国产企业双线发力
每日卖空追踪 | 三生制药 01月12日卖空量成交95.7万股,卖空比例为3.27%
市场透视 · 01-12 16:30
每日卖空追踪 | 三生制药 01月12日卖空量成交95.7万股,卖空比例为3.27%
“年度最具成长潜力公司”揭晓:三生制药、华虹、泡泡玛特皆入榜
港股解码 · 01-09
“年度最具成长潜力公司”揭晓:三生制药、华虹、泡泡玛特皆入榜
【券商聚焦】招银国际指春季反弹可期,看好科技与消费板块
金吾财讯 · 01-09
【券商聚焦】招银国际指春季反弹可期,看好科技与消费板块
每日卖空追踪 | 三生制药 01月08日卖空量成交432.85万股,卖空比例为11.93%
市场透视 · 01-08
每日卖空追踪 | 三生制药 01月08日卖空量成交432.85万股,卖空比例为11.93%
三生制药01月08日遭主力抛售6716.6万元
市场透视 · 01-08
三生制药01月08日遭主力抛售6716.6万元
1月7日港股药品及生物科技行业沽空数据盘点,石药集团、三生制药、晶泰控股沽空金额位居行业前三
证券之星APP · 01-07
1月7日港股药品及生物科技行业沽空数据盘点,石药集团、三生制药、晶泰控股沽空金额位居行业前三
每日卖空追踪 | 三生制药 01月07日卖空量成交429.25万股,卖空比例为8.9%
市场透视 · 01-07
每日卖空追踪 | 三生制药 01月07日卖空量成交429.25万股,卖空比例为8.9%
三生制药盘中异动 快速拉升5.18%报27.620港元
市场透视 · 01-07
三生制药盘中异动 快速拉升5.18%报27.620港元
罕见病创新药内地首张处方药开出 港股通创新药ETF板块迎双重驱动
财闻 · 01-07
罕见病创新药内地首张处方药开出 港股通创新药ETF板块迎双重驱动
三生制药(01530)12月股份变动月报:新增发行约1.05亿股,总股本升至25.38亿股
公告速递 · 01-05
三生制药(01530)12月股份变动月报:新增发行约1.05亿股,总股本升至25.38亿股
每日卖空追踪 | 三生制药 01月05日卖空量成交240.65万股,卖空比例为6.54%
市场透视 · 01-05
每日卖空追踪 | 三生制药 01月05日卖空量成交240.65万股,卖空比例为6.54%
三生制药01月05日主力净流入1295.4万元 散户资金抛售
市场透视 · 01-05
三生制药01月05日主力净流入1295.4万元 散户资金抛售
三生制药盘中异动 早盘股价大涨5.13%
市场透视 · 01-05
三生制药盘中异动 早盘股价大涨5.13%
光鲜下的另一面,BD交易后股价不涨反跌成常态?专家:短期热度降低不是坏事
时代周报 · 2025-12-25
光鲜下的另一面,BD交易后股价不涨反跌成常态?专家:短期热度降低不是坏事
中国创新药“闯关”海外市场,如何实现全球价值兑现?
21世纪经济报道 · 2025-12-25
中国创新药“闯关”海外市场,如何实现全球价值兑现?
三生制药12月24日主力净流出97.6万元 散户资金买入
市场透视 · 2025-12-24
三生制药12月24日主力净流出97.6万元 散户资金买入
加载更多
公司概况
公司名称:
三生制药
所属市场:
SEHK
上市日期:
--
主营业务:
3SBio Inc是一家主要从事生物制药产品的开发、生产、市场推广及销售的投资控股公司。该公司的主要产品包括特比澳、益比奥、益赛普、赛普汀等生物药物以及蔓迪、丽美治等小分子药物。该公司还从事为客户提供多种生物药的研发生产以及治疗技术平台服务的合同开发与生产运营(CDMO)业务。该公司的产品主要应用于血小板减少症(CIT)、慢性肾病(CKD)引起的贫血症、治疗化疗引起的贫血症(CIA)、强直性嵴柱炎(AS)及银屑病等。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"三生制药","latestPrice":27.32,"timestamp":1768378086004,"preClose":28.32,"halted":0,"volume":36774695,"delay":0,"floatShares":2538000000,"shares":2538000000,"eps":0.9647117337221816,"marketStatus":"未开盘","change":-1,"latestTime":"01-14 16:08:06","open":28.58,"high":28.8,"low":26.62,"amount":1006809664,"amplitude":0.076977,"askPrice":27.32,"askSize":20000,"bidPrice":27.3,"bidSize":44500,"shortable":3,"etf":0,"ttmEps":1.0725006855164454,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768440600000},"marketStatusCode":0,"adr":0,"listingDate":1433952000000,"exchange":"SEHK","adjPreClose":28.32,"dividendRate":0.009151,"openAndCloseTimeList":[[1768354200000,1768363200000],[1768366800000,1768377600000]],"volumeRatio":1.096305,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01530","defaultTab":"news","newsList":[{"id":"1137978914","title":"港股创新药概念股盘初普涨!乐普生物-B涨超8%,药明康德涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137978914","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137978914?lang=zh_cn&edition=full","pubTime":"2026-01-13 09:45","pubTimestamp":1768268737,"startTime":"0","endTime":"0","summary":"1月13日,港股创新药概念股盘初普涨,$乐普生物-B(02157)$涨超8%,$药明康德(02359)$涨超7%,$三生制药(01530)$、$晶泰控股(02228)$涨超6%,$歌礼制药-B(01672)$涨超4%,$复星医药(02196)$、$云顶新耀(01952)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d9a285c5d35960016c392e2c485f56f0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1161","01530","01672","02228","02359","LU2045819591.USD","BK1617","LU2125910500.SGD","01952","HK0000165453.HKD","02157","BK1515","02196","LU0320764599.SGD","BK1141","BK1593","BK1574","LU0052750758.USD","LU2242644610.SGD","BK1576","BK1583","LU1046422090.SGD","01477","LU0708995583.HKD"],"gpt_icon":0},{"id":"2603754420","title":"蔓迪国际的两重隐忧:脱发产品或被集采,减肥药又难破“双寡头”格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2603754420","media":"新财观","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603754420?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:15","pubTimestamp":1768209336,"startTime":"0","endTime":"0","summary":"但身披“脱发茅”这件华丽外衣下,蔓迪国际也还暗含两大隐忧:一是,核心业务“米诺地尔”脱发药品或将存在集采的可能;二是,被寄予厚望的第二曲线“司美格鲁肽”减肥药上市后,面对诺和诺德与礼来“双寡头”的垄断下,又能否迎来爆发仍然是个未知数?据了解,蔓迪国际待上市的减肥药产品司美格鲁肽注射液系国内原研药公司瀚宇药业研发,双方于2024年5月28日签署独家代理合作协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112192100a4ba72a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112192100a4ba72a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","HK0000165453.HKD","BK1583","BK1593","BK1161"],"gpt_icon":0},{"id":"2602933518","title":"JPM 2026前瞻 | 中国创新药站上全球舞台中央","url":"https://stock-news.laohu8.com/highlight/detail?id=2602933518","media":"Ofweek光电信息网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602933518?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:58","pubTimestamp":1768208280,"startTime":"0","endTime":"0","summary":"2026年第44届摩根大通医疗健康大会将于1月12日至15日在美国旧金山举行。据披露,本届JPM的议题与参会企业或将高度集中于六大核心领域,其中生物技术板块占比最高,预计接近35%。目前,已有多家国内企业确认参会,且覆盖CXO与创新药两大核心群体。从行业趋势看,本届JPM或将进一步强化两条技术主线。进入2026年,这一趋势仍在延续。宜联生物B7H3 ADC授权给罗氏此次JPM 2026将成为国内药企集中展示核心分子竞争力、推动海外BD合作的重要窗口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112173836a710ffe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112173836a710ffe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06160","02269","LU2328871848.SGD","03696","BK1583","06978","09995","02359","BK1161","LU1969619763.USD","09688","01530","01276","02615"],"gpt_icon":0},{"id":"2602902425","title":"中国力量在JPM大会的闪耀时刻:24家国产企业双线发力","url":"https://stock-news.laohu8.com/highlight/detail?id=2602902425","media":"药渡","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602902425?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:36","pubTimestamp":1768206992,"startTime":"0","endTime":"0","summary":"而今年,中国力量成为舞台上最耀眼的星光之一:24家国产医药企业集体亮相,以“主会场引领、亚太专场扩容”的双线布局,向世界展示中国医药产业的创新硬实力与全球化野心。结 语从主会场的核心发声到亚太专场的集体亮相,24家中国药企在JPM大会的舞台上,用实打实的研发成果、商业化突破与海外合作,书写着中国医药的全球化篇章。这不仅是中国力量的闪耀时刻,更预示着2026年中国创新药将在全球舞台上迎来更多突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112165035a710cae5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112165035a710cae5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1719994722.HKD","LU2328871848.SGD","BK1161","BK1588","LU2488822045.USD","LU1303224171.USD","LU0307460666.USD","BK1574","LU1770034418.SGD","02359","BK1583","01530","BK1500","06990","09995","06160","09688","LU1969619763.USD","LU0588546209.SGD","02269","01276","06978","LU1251922891.USD"],"gpt_icon":0},{"id":"2603544785","title":"每日卖空追踪 | 三生制药 01月12日卖空量成交95.7万股,卖空比例为3.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603544785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603544785?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:30","pubTimestamp":1768206620,"startTime":"0","endTime":"0","summary":"三生制药北京时间01月12日,跌2.02%,卖空量成交95.7万股,较上一交易日减少70.02%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164723a4b9d243&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164723a4b9d243&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","01530","HK0000165453.HKD","BK1583"],"gpt_icon":0},{"id":"2602371765","title":"“年度最具成长潜力公司”揭晓:三生制药、华虹、泡泡玛特皆入榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2602371765","media":"港股解码","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602371765?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:45","pubTimestamp":1767951913,"startTime":"0","endTime":"0","summary":"2025香港财富管理高峰论坛暨第十二届港股100强颁奖盛典正在隆重举行,备受市场关注的“年度最具成长潜力公司”榜单正在揭晓,20家来自生物科技、半导体、新消费等高增长赛道的企业成功入选。三生制药(01530.HK)、华虹半导体(01347.HK)、复宏汉霖(02696.HK)、泡泡玛特(09992.HK)、古茗(01364.HK)、西锐(02507.HK)等企业凭借高成长性表现跻身榜单。该奖项以营业额、税后净利润、总回报率作为核心评价指标,结合创新能力与战略前瞻性进行综合评定,旨在发掘具备持续增长动力与行业引领能力的未来之星。作者|遥远编辑|Danna","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109175903a4afd92e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109175903a4afd92e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","SG9999002950.SGD","BK1614","LU0307460666.USD","LU0708995583.HKD","SG9999006597.SGD","BK1607","LU0359201885.HKD","SGXZ62798434.SGD","LU0499858602.USD","LU0611395673.USD","LU0871576103.HKD","BK1589","LU1023057109.AUD","LU0345776255.USD","BK1224","LU0231483743.USD","LU0327786744.USD","LU0359201612.USD","LU0359202008.SGD","BK1163","01347","LU0164880469.USD","LU1770036033.HKD","LU0211977185.USD","LU0823426480.USD","LU1481107354.HKD","LU0320764599.SGD","SG9999001069.SGD","LU0572944931.SGD","LU0039217434.USD","IE0034224299.USD","BK1593","01530","LU0345775950.USD","LU0164865239.USD","BK1161","LU0593848301.USD","09992","LU0499858438.USD","LU0823426308.USD","LU2543165471.USD","LU0149721374.USD","LU0348767384.USD","SGXZ86797644.SGD","HK0000165453.HKD","LU0348766576.USD","LU0588546209.SGD","BK1583","LU0531971595.HKD"],"gpt_icon":0},{"id":"2602419346","title":"【券商聚焦】招银国际指春季反弹可期,看好科技与消费板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2602419346","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602419346?lang=zh_cn&edition=full","pubTime":"2026-01-09 10:41","pubTimestamp":1767926499,"startTime":"0","endTime":"0","summary":"金吾财讯|招银国际发布研报指,前一交易日恒生指数上涨5.3%,重点地产股与物业股分别上涨6.5%和6.2%。报告预计2026年中国GDP增速将放缓至4.8%,但通缩压力有望改善,宏观政策或进一步宽松,股市可能迎来春季反弹。消费板块呈现\"降级\"特征,建议关注农夫山泉、锅圈等防御性标的。汽车行业预计2026年新能源车销量增长18.5%,推荐吉利汽车。保险板块有望迎来\"戴维斯双击\",推荐中国平安目标价75港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109110252a4ae632f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109110252a4ae632f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01109","02318","00175","601318","LU1303224171.USD","BK1570","LU0588545904.SGD","HPAD.SI","LU0588546209.SGD","LU1224444064.USD","LU0370786039.SGD","02018","LU0605514214.HKD","LU0918141887.USD","02338","EVS.SI","LU0348827113.USD","LU1226287529.USD","SG9999004220.SGD","LU1051769294.HKD","LU0634319403.HKD","LU2348774022.SGD","01530","LU0531971595.HKD","LU0414403682.SGD","PAImain","LU0979878070.USD","BK1589","LU1807302812.USD","LU0067412154.USD","LU0235996351.USD","03145","LU2088748293.HKD","82318","PNGAY","LU0791591158.USD","BK1522","02273","09633","LU1008478684.HKD","BK1184","LU0417516738.SGD","BK1608","LU0828237940.HKD","LU0865486749.SGD","GELYY","02517","IE0008368742.USD","80175","06031"],"gpt_icon":1},{"id":"2601039350","title":"每日卖空追踪 | 三生制药 01月08日卖空量成交432.85万股,卖空比例为11.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601039350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601039350?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861023,"startTime":"0","endTime":"0","summary":"三生制药北京时间01月08日,跌2.27%,卖空量成交432.85万股,较上一交易日减少62.05%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164510a4ab4311&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164510a4ab4311&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1583","HK0000165453.HKD","01530","BK1161"],"gpt_icon":0},{"id":"2601139352","title":"三生制药01月08日遭主力抛售6716.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601139352","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601139352?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:15","pubTimestamp":1767860151,"startTime":"0","endTime":"0","summary":"01月08日, 三生制药股价跌2.27%,报收27.50元,成交金额10.2亿元,换手率1.43%,振幅6.33%,量比1.22。三生制药今日主力资金净流出6716.6万元,连续3日净流出,上一交易日主力净流出4010.7万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为2.78%。该股近5个交易日上涨13.90%,主力资金累计净流出1.2亿元;近20日主力资金累计净流出2.9亿元,其中净流出天数为14日。该股主力净额占比0.10%,港股市场排名2656/2713。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162631a4ab2fdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162631a4ab2fdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01530","BK1583","HK0000165453.HKD","BK1593"],"gpt_icon":0},{"id":"2601942338","title":"1月7日港股药品及生物科技行业沽空数据盘点,石药集团、三生制药、晶泰控股沽空金额位居行业前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2601942338","media":"证券之星APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601942338?lang=zh_cn&edition=full","pubTime":"2026-01-07 18:06","pubTimestamp":1767780400,"startTime":"0","endTime":"0","summary":"证券之星消息,1月7日港交所披露数据显示,当日港股药品及生物科技行业的161只个股中有81只被沽空,总沽空股数为1.57亿股,总沽空金额为29.46亿元(港元),而当日药品及生物科技行业的总成交金额为225.42亿元(港元),沽空比例为13.07%。从沽空金额来看,石药集团、三生制药、晶泰控股沽空金额位居行业前三,分别为3.26亿港元、3.12亿港元、2.99亿港元。沽空与卖空含义相同,即在并不持有股票的前提下,通过借入股票获得筹码进而卖出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107181809a6fe4cd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107181809a6fe4cd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226288170.HKD","IE0008368742.USD","LU0880133367.SGD","LU0072913022.USD","IE00BZ08YR35.GBP","LU1226288253.USD","LU0501845795.SGD","LU1152091754.HKD","HK0000165453.HKD","LU0315179316.USD","IE0008369823.USD","LU1226287792.SGD","LU1226287529.USD","LU1813983027.USD","IE00B031HY20.USD","LU1328277881.USD","LU1226287875.USD","BK1593","IE00BZ08YT58.USD","LU1807302812.USD","LU2039709279.SGD","BK1617","LU0314109678.HKD","LU0326950275.SGD","02228","01530","IE00B543WZ88.USD","BK1191","BK1141","LU0140636845.USD","LU1008478684.HKD","BK1161","BK1521","LU1152091168.USD","IE00BZ08YS42.EUR","LU1960683339.HKD","IE00B5MMRT66.SGD","BK1515","LU0067412154.USD","LU1951186391.HKD","LU1993786604.SGD","SG9999004220.SGD","01093","BK1583"],"gpt_icon":0},{"id":"2601800628","title":"每日卖空追踪 | 三生制药 01月07日卖空量成交429.25万股,卖空比例为8.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601800628","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601800628?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:30","pubTimestamp":1767774622,"startTime":"0","endTime":"0","summary":"三生制药北京时间01月07日,涨7.16%,卖空量成交429.25万股,较上一交易日减少7.12%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163307a4a6e4ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163307a4a6e4ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","01530","HK0000165453.HKD","BK1583"],"gpt_icon":0},{"id":"2601006238","title":"三生制药盘中异动 快速拉升5.18%报27.620港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601006238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601006238?lang=zh_cn&edition=full","pubTime":"2026-01-07 14:57","pubTimestamp":1767769040,"startTime":"0","endTime":"0","summary":"2026年01月07日下午盘14时57分,三生制药股票出现波动,股价大幅上涨5.18%。截至发稿,该股报27.620港元/股,成交量3417.21万股,换手率1.35%,振幅5.41%。资金方面,该股资金流入4.7374亿港元,流出3.36939亿港元。最近的财报数据显示,该股实现营业收入47.76亿港元,净利润14.89亿港元,每股收益0.63港元,毛利40.75亿港元,市盈率31.08倍。三生制药股票所在的药品行业中,整体涨幅为1.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010714572097a12c3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010714572097a12c3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01530","BK1593","BK1161","HK0000165453.HKD"],"gpt_icon":0},{"id":"2601825895","title":"罕见病创新药内地首张处方药开出 港股通创新药ETF板块迎双重驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2601825895","media":"财闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601825895?lang=zh_cn&edition=full","pubTime":"2026-01-07 11:27","pubTimestamp":1767756474,"startTime":"0","endTime":"0","summary":"近日,罕见病创新药司拉德帕在中国内地开出了首张处方。创新药物将走入更多寻常百姓家。1月7日,盘中港股创新药持续走强。港股通创新药ETF嘉实盘中涨超3%。2026年我国医药生物行业将正式步入创新药大时代,创新药将逐渐占据我国医药生物行业的主导地位,医保商保的互补结合将长期打开支付空间的天花板,创新药将持续蓬勃发展。创新药产业链行业,受益于创新药的快速发展预计仍将保持良好增长势头。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107112826a6fcca5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107112826a6fcca5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","02157","09926","06978","BK1574","01530","BK1161","03347","BK1141","BK1583"],"gpt_icon":0},{"id":"1183855732","title":"三生制药(01530)12月股份变动月报:新增发行约1.05亿股,总股本升至25.38亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1183855732","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183855732?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:41","pubTimestamp":1767602493,"startTime":"0","endTime":"0","summary":"三生制药于2026年1月5日发布12月股份变动月报,报告期为2025年12月1日至12月31日。公告显示,公司法定股本维持不变,仍为50,000,000,000股普通股,面值每股USD 0.00001,总额USD 500,000。本月已发行股份自上月的2,432,833,912股增加至2,538,005,412股,总增幅为105,171,500股。报告期内,公司无已购回、赎回或注销股份的记录。截至12月31日,公司已发行股份总数增至2,538,005,412股。本次公告由公司秘书黎少娟签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"gpt_icon":0},{"id":"2601832611","title":"每日卖空追踪 | 三生制药 01月05日卖空量成交240.65万股,卖空比例为6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601832611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601832611?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:30","pubTimestamp":1767601821,"startTime":"0","endTime":"0","summary":"三生制药北京时间01月05日,涨5.7%,卖空量成交240.65万股,较上一交易日增加332.82%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163502a6f523ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163502a6f523ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1583","BK1161","HK0000165453.HKD","01530"],"gpt_icon":0},{"id":"2601623832","title":"三生制药01月05日主力净流入1295.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601623832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601623832?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:16","pubTimestamp":1767600967,"startTime":"0","endTime":"0","summary":"01月05日, 三生制药股价涨5.70%,报收25.98元,成交金额9.4亿元,换手率1.45%,振幅11.07%,量比1.77。三生制药今日主力资金净流入1295.4万元,上一交易日主力净流出1789.6万元。该股近5个交易日上涨0.77%,主力资金累计净流出2350.0万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入8655.7万元,其中净流入天数为9日。该股主力净额占比0.02%,港股市场排名306/2709。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162411a49e1b8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162411a49e1b8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","BK1593","HK0000165453.HKD","BK1583","BK1161"],"gpt_icon":0},{"id":"2601647832","title":"三生制药盘中异动 早盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601647832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601647832?lang=zh_cn&edition=full","pubTime":"2026-01-05 10:36","pubTimestamp":1767580568,"startTime":"0","endTime":"0","summary":"2026年01月05日早盘10时36分,三生制药股票出现波动,股价大幅上涨5.13%。截至发稿,该股报25.840港元/股,成交量1653.2万股,换手率0.65%,振幅9.19%。三生制药股票所在的药品行业中,整体涨幅为1.08%。其相关个股中,中智药业、中国同辐、信达生物涨幅较大,振幅较大的相关个股有宝济药业-B、中智药业、三生制药,振幅分别为11.76%、10.00%、9.19%。三生制药公司简介:投资控股,及本集团主要在中国从事开发、生产、营销及销售生物医药产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105103608a49ceb3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105103608a49ceb3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000165453.HKD","BK1593","BK1583","01530"],"gpt_icon":0},{"id":"2594287939","title":"光鲜下的另一面,BD交易后股价不涨反跌成常态?专家:短期热度降低不是坏事","url":"https://stock-news.laohu8.com/highlight/detail?id=2594287939","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594287939?lang=zh_cn&edition=full","pubTime":"2025-12-25 14:21","pubTimestamp":1766643688,"startTime":"0","endTime":"0","summary":"今年创新药企业频繁宣布BD交易,但从三季度以来,原本利好的消息却不被二级市场买账。最近一周,BD交易再掀一个小高潮。12月22日,先声药业(02096.HK)宣布其附属公司江苏再明与Ipsen于12月19日签订独家授权许可协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512253601825588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09995","03692","LU2097828474.EUR","688336","LU2097828805.USD","LU0502904849.HKD","BK0057","LU1064131003.USD","LU1328615791.USD","002755","LU2488822045.USD","LU2148510915.USD","BK1161","02142","02096","LU2097828557.USD","LU1781817850.SGD","LU0405327148.USD","LU1146622755.USD","LU0405327494.USD","02509","600276","BK0196","LU2580892862.HKD","01801","LU1997245094.SGD","BK1593","688062","BK0239","BK0060","BK1589","LU1969619763.USD","LU2097828714.EUR","LU1064130708.USD","LU1997245177.USD","BK0188","LU2097828631.EUR","01167","BK0183","LU1997244956.HKD","603087","000661","BK1574","688331","01530","BK0012","06978","LU2495084118.USD","BK0028","688428"],"gpt_icon":0},{"id":"2594928361","title":"中国创新药“闯关”海外市场,如何实现全球价值兑现?","url":"https://stock-news.laohu8.com/highlight/detail?id=2594928361","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594928361?lang=zh_cn&edition=full","pubTime":"2025-12-25 08:21","pubTimestamp":1766622108,"startTime":"0","endTime":"0","summary":"从长期来看,中国创新药市场规模有望持续增长,到2030年,中国创新药行业市场规模将接近2.3万亿元。完成审评5848个品种,同比增长9.49%;共计批准创新药上市54个品种。BD“造血”其实,2025年中国创新药行业最显著的特点,就是BD交易从“火热”到“价值兑现”的实质性跨越。这显示出中国创新资产在全球定价权的重要地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225082633a4751dd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225082633a4751dd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01276","02615","06978","02142","01801","01530","BK1161"],"gpt_icon":0},{"id":"2594285602","title":"三生制药12月24日主力净流出97.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2594285602","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594285602?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:15","pubTimestamp":1766564157,"startTime":"0","endTime":"0","summary":"12月24日, 三生制药股价跌1.37%,报收25.88元,成交金额1.7亿元,换手率0.26%,振幅3.05%,量比0.38。三生制药今日主力资金净流出97.6万元,上一交易日主力净流入329.6万元。该股近5个交易日上涨0.31%,主力资金累计净流出2727.8万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1.0亿元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224162157a47270df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224162157a47270df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1583","BK1593","01530","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3sbio.com","stockEarnings":[{"period":"1week","weight":-0.0291},{"period":"1month","weight":0.0412},{"period":"3month","weight":-0.0631},{"period":"6month","weight":-0.1215},{"period":"1year","weight":3.7812},{"period":"ytd","weight":0.1299}],"compareEarnings":[{"period":"1week","weight":0.0204},{"period":"1month","weight":0.0535},{"period":"3month","weight":0.0429},{"period":"6month","weight":0.0876},{"period":"1year","weight":0.4048},{"period":"ytd","weight":0.0534}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"3SBio Inc是一家主要从事生物制药产品的开发、生产、市场推广及销售的投资控股公司。该公司的主要产品包括特比澳、益比奥、益赛普、赛普汀等生物药物以及蔓迪、丽美治等小分子药物。该公司还从事为客户提供多种生物药的研发生产以及治疗技术平台服务的合同开发与生产运营(CDMO)业务。该公司的产品主要应用于血小板减少症(CIT)、慢性肾病(CKD)引起的贫血症、治疗化疗引起的贫血症(CIA)、强直性嵴柱炎(AS)及银屑病等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.008454},{"month":2,"riseRate":0.5,"avgChangeRate":0.007795},{"month":3,"riseRate":0.8,"avgChangeRate":0.121345},{"month":4,"riseRate":0.4,"avgChangeRate":-0.014398},{"month":5,"riseRate":0.7,"avgChangeRate":0.109101},{"month":6,"riseRate":0.8,"avgChangeRate":0.036581},{"month":7,"riseRate":0.090909,"avgChangeRate":-0.038254},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.014022},{"month":9,"riseRate":0.636364,"avgChangeRate":0.027455},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.018307},{"month":11,"riseRate":0.727273,"avgChangeRate":0.059913},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.045323}],"exchange":"SEHK","name":"三生制药","nameEN":"3SBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三生制药,01530,三生制药股票,三生制药股票老虎,三生制药股票老虎国际,三生制药行情,三生制药股票行情,三生制药股价,三生制药股市,三生制药股票价格,三生制药股票交易,三生制药股票购买,三生制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}